Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement

Recruiting now

Conditions studied: Takayasu Arteritis With Pulmonary Artery Involvement, Percutaneous Transluminal Pulmonary Angioplasty, PAH Targeted Medication

In brief

1. Evaluate the effect of medical treatment and percutaneous transluminal pulmonary angioplasty on takayasu arteritis with pulmonary artery involvement 2. evaluate the efficacy of FAPI in predicting the activity and treatment efficacy of takayasu arteritis with pulmonary artery involvement

Key facts

Study ID

NCT05388682

Run by

Chinese Pulmonary Vascular Disease Research Group

People needed

200

Starts

2014-01-19

Expected to finish

2042-12-31

Last updated by the study team

2023-12-20

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patients diagnosed with Takayasu arteries with pulmonary arteries involvement

You may not qualify if…

• Patients had pulmonary artery stenosis arising from CTEPH, fibrosing mediastinitis and congenital pulmonary artery stenosis

Where it is running

• Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College — Beijing, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.